Wave Life Sciences, Inc. WVE

WVE Company Overview

WAVE Life Sciences Ltd. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing RNA-based medicines. The company operates within the biotechnology and pharmaceutical industries, with a core emphasis on genetic medicines that target the root causes of disease by selectively modulating RNA. Its approach is differentiated by the use of stereopure oligonucleotides, which are designed to enhance potency, specificity, and durability compared with traditional RNA therapeutics.

The company’s primary revenue drivers to date are collaboration and research revenues, milestone payments, and, to a lesser extent, grant funding, as it has not yet commercialized an approved product. WAVE Life Sciences primarily serves patients with rare genetic, neurological, and cardiometabolic diseases, often addressing conditions with high unmet medical need. Founded in 2012, the company was established to commercialize advances in stereochemistry applied to nucleic acid therapeutics and has evolved from early research-stage programs to a pipeline that includes multiple clinical-stage candidates.